labetalol has been researched along with 15-hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic acid in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Forman, A; Gregersen, H; Petersen, OB; Skajaa, K; Svane, D | 1 |
| Semczuk, M; Skoczyński, M | 1 |
2 other study(ies) available for labetalol and 15-hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic acid
| Article | Year |
|---|---|
The effects of dihydralazine, labetalol and magnesium sulphate on the isolated, perfused human placental cotyledon.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Dihydralazine; Dose-Response Relationship, Drug; Female; Humans; In Vitro Techniques; Labetalol; Magnesium Sulfate; Placenta; Pregnancy; Prostaglandin Endoperoxides, Synthetic; Thromboxane A2; Vasoconstrictor Agents; Vasodilation | 1994 |
[Influence of labetalol on the resistance of human fetoplacental vessels in perfusion in vitro].
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Dose-Response Relationship, Drug; Female; Fetus; Humans; In Vitro Techniques; Labetalol; Placenta; Placental Circulation; Pregnancy; Thromboxane A2; Vascular Resistance; Vasoconstrictor Agents | 2002 |